Widely studied transgenic mouse models of AD, Tg2576, APP23, APPswe are over-expressing APP with a Swedish mutation [32, 33], hence affording limited control of the resulting Aβ peptides following β- and γ-secretase cleavage and proteolytic processing. This evidence concerns the gene APP and Alzheimer disease.